Dr. Liraz Levi joins as VP and Director of Scientific Operations, Small Molecule Program

Dr. Liraz Levi joins Celloram as VP and Director of Scientific Operations of our Small

Molecule Program. Dr. Levi completed her Ph.D. at The Hebrew University of

Jerusalem and previously served as a principal investigator in the Case Comprehensive

Cancer Center at Case Western Reserve University.

Dr. Levi’s research began with an interest in dietary nutrients and how they affect

molecular processes in the body. Her research has since expanded into how fatty acids

and other small molecules can enhance or disrupt the processes that regulate cancer

cells and metabolic diseases.

Dr. Levi is a welcome and valued addition to Celloram and our Small Molecule Program.

Dr. Seunghwan Lim joins Celloram as VP and Director of Scientific Operations of our Cell Therapy Program

Dr. Seunghwan Lim joins Celloram as VP and Director of Scientific Operations of our Cell Therapy Program. Dr. Lim completed his Ph.D. in cancer biology and therapeutics development at SUNY Upstate Medical University and his postdoctoral training at the National Cancer Institute, NIH and Case Western Reserve University.

His research interests largely focus on cellular signaling events, specifically the TGF-β signaling pathway. TGF-β is a multifunctional cytokine that plays an important role in regulating malignant cancer behaviors.

“With over 20 years of research experiences, I feel like I have to use this knowledge to develop something more special that can save some lives” says Dr. Lim.

We are thrilled to welcome Dr. Lim to Team Celloram.